Verrica Pharmaceuticals (VRCA) Debt to Equity Ratio: 0.4202

Verrica Pharmaceuticals, Inc. (VRCA)

4.10 -0.08 (-1.91%) USD | NASDAQ | Oct 09, 16:00

4.10 0.00 (0.00%) After-Hours: 20:00

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2017. Start Trial.

Date	Value
June 30, 2026	0.4202
March 31, 2026	0.0898
December 31, 2025	0.0659
September 30, 2025	-2.097
June 30, 2025	-2.224
March 31, 2025	-2.284
December 31, 2024	-4.659
September 30, 2024	-1.384
June 30, 2024	-3.482
March 31, 2024	30.72
December 31, 2023	2.303
September 30, 2023	1.036
June 30, 2023	0.0249
March 31, 2023	0.0224
December 31, 2022	0.0381
September 30, 2022	0.0356
June 30, 2022	2.692
March 31, 2022	1.717

Date	Value
December 31, 2021	1.331
September 30, 2021	1.056
June 30, 2021	0.8214
March 31, 2021	0.6881
December 31, 2020	1.128
September 30, 2020	0.9331
June 30, 2020	0.719
March 31, 2020	0.611
December 31, 2019	0.0029
September 30, 2019	0.003
June 30, 2019	0.0032
March 31, 2019	0.0034
December 31, 2018	0.00
September 30, 2018	0.00
June 30, 2018	0.00
March 31, 2018	0.0002
December 31, 2017	0.00

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks